Target intelligence / Profile preview

GRAM domain-containing protein 1B (GRAMD1B)

Target
GRAMD1B
Molecular classification
Lipid transfer protein, Cholesterol transport protein, Integral membrane protein, Other
01

Overview

GRAM domain-containing protein 1B (GRAMD1B, also known as Aster-B and KIAA1201) is an integral membrane cholesterol transport protein anchored to the endoplasmic reticulum[1]. It contains a GRAM domain and a VASt (StAR-related lipid transfer) domain, which together enable the protein to mediate the nonvesicular transport of cholesterol from the plasma membrane to the endoplasmic reticulum at membrane contact sites, particularly in response to high cholesterol load[1][2][3][4]. GRAMD1B is highly conserved across species, expressed in many human tissues (notably adrenal gland, gonads, brain, and placenta), and plays critical roles in cellular lipid regulation, autophagy, and maintenance of cholesterol homeostasis. In neuronal systems, it impacts tau phosphorylation and clearance via the autophagy pathway, with implications for neurodegenerative disease pathogenesis[3]. Experimentally, AI-3d can inhibit GRAMD1B, impacting cholesterol and tau regulation, but broader drug targeting remains limited. There are no current safety reports specific to its therapeutic targeting, but loss of function impairs cholesterol and lipid trafficking, indicating potential for homeostatic disruption[3].

Other names
Protein Aster-BKIAA1201UNQ3032/PRO9834Aster-BGRAM domain-containing protein 1Blong intergenic non-protein coding RNA 1059LINC01059
02

Mechanism of action

Inhibition of nonvesicular cholesterol transfer and lipid trafficking

03

Biological functions

Nonvesicular cholesterol transportLipid homeostasisRegulation of autophagyTau phosphorylation regulationCholesterol sensing and trafficking
04

Disease associations

Neurodegenerative disease (e.g., tauopathy, Alzheimer's disease)Endocrine/adrenal diseaseOther
05

Safety considerations

Potential disruption of lipid homeostasis and autophagic flux if inhibited
06

Interacting drugs

AI-3d (Aster inhibitor)
07

Biomarkers

Tau phosphorylation state in neurons/brain tissue

Beyond the preview

Go deeper on GRAM domain-containing protein 1B (GRAMD1B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRAM domain-containing protein 1B (GRAMD1B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call